Know Cancer

forgot password

Multimodality Statistical Model of Early Response of High Grade Glioma to Radiation Therapy

18 Years
Not Enrolling
Brain Tumor

Thank you

Trial Information

Multimodality Statistical Model of Early Response of High Grade Glioma to Radiation Therapy

Detailed DescriptionOBJECTIVES:

I. To develop a multimodality statistical model to act as a surrogate marker scheme of early
changes in high grade glioma patients undergoing radiation therapy, using conventional MRI,
MR diffusion tensor imaging, perfusion, permeability, and spectroscopic imaging while
incorporating the radiation dose calculations delivered locally and the results of a
clinical questionnaire into the model.

II. To assess treatment response to tumor and normal tissue changes. OUTLINE: Patients
undergo multimodality MRI imaging at baseline, weeks 1, 2, 3, 5, and 6, and then 4-6 weeks
after completion of radiation therapy.

Inclusion Criteria:

- Patients being treated for diagnosed with high grade glioma (WHO grade III or IV) at
the University of Pennsylvania Medical Center who will be undergoing radiation
therapy to the brain

- Patient or legal representative able to provide written informed consent

- Adult males and nonpregnant females

Exclusion Criteria:

- Vulnerable populations as specified (including pregnant patients, prisoners, patients
with pacemakers or metallic implants)

- Patients with renal failure

- Patients with any condition considered a contraindication to MRI

Type of Study:


Study Design:

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

Early brain tumor response

Safety Issue:



United States: Institutional Review Board

Study ID:

UPCC 12309



Start Date:

July 2009

Completion Date:

December 2012

Related Keywords:

  • Brain Tumor
  • Adult Brain Tumor
  • Brain Neoplasms



Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, Pennsylvania  19104-4283